共 378 条
[1]
Han Y(2015)Cost-effectiveness analysis of strategies introducing integrated 18F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer Nucl Med Commun 36 234-41
[2]
Xiao H(2013)Development of PET in Western Europe (abstract OP 104) Eur J Nucl Med Mol Imaging 40 S1-477
[3]
Zhou Z(2013)Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 e93S-120
[4]
Yuan M(2013)Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 e437S-54
[5]
Zeng Y(2013)Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 e211S-50
[6]
Wu H(2013)Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 e142S-65
[7]
Stevens AN(2014)Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer Eur J Cardiothorac Surg 45 787-98
[8]
Gould MK(2012)Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 23 vii56-64
[9]
Donington J(2013)Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 24 vi89-98
[10]
Lynch WR(1997)Systematic reviews: synthesis of best evidence for clinical decisions Ann Intern Med 126 376-80